Increase of core temperature induced by corticotropin-releasing factor and urocortin: A comparative study

Regulatory Peptides

Volumn 165, Issue 2-3, 2010, Pages 191-199

  Figueiredo, M J ^a   Fabricio, A S C ^a,b   Machado, R R ^a   Melo, M C C ^a   Soares, D M ^a   Souza, G E P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Venice Hospital   (Italy)

Author keywords

CRF receptors; Cyclooxygenase inhibitor; Fever; Hyperthermia

Indexed keywords

ANTALARMIN; ASTRESSIN; CELECOXIB; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; INDOMETACIN; UROCORTIN I;

ANIMAL EXPERIMENT; ANTIPYRETIC ACTIVITY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CORE TEMPERATURE; FEVER; HORMONE ACTION; HYPERTHERMIA; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECTUM TEMPERATURE; SKIN TEMPERATURE; THERMOREGULATION;

ANIMALS; ANTIPYRETICS; BODY TEMPERATURE; CORTICOTROPIN-RELEASING HORMONE; MALE; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UROCORTINS;

RATTUS; RATTUS NORVEGICUS;

EID: 78649900480     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.07.167     Document Type: Article

References (86)

1. Saper C.B. Neurobiological basis of fever. Ann NY Acad Sci 1998, 856:90-94.
2. Zampronio A.R., Melo M.C., Silva C.A., Pelá I.R., Hopkins S.J., Souza G.E. A pre-formed pyrogenic factor released by lipopolysaccharide stimulated macrophages. Mediators Inflamm 1994, 3:365-373.
3. Machado R.R., Soares D.M., Proudfoot A.E., Souza G.E.P. CCR1 and CCR5 chemokine receptors are involved in fever induced by LPS (E. coli) and RANTES in rats. Brain Res 2007, 1161:21-31.
4. Melo Soares D., Hiratsuka Veiga-Souza F., Sueli Coelho Fabricio A., Javier Minano F., Petto Souza G.E. CCL3/macrophage inflammatory protein-1α induces fever and increases prostaglandin E2 in cerebrospinal fluid of rats: effect of antipyretic drugs. Brain Res 2006, 1109:83-92.
5. Fernández-Alonso A., Miñano F.J., Myers R.D. Fever induced in rats by intrahypothalamic macrophage inflammatory protein (MIP)-1 beta: role of protein synthesis. J Neurosci Res 1995, 42:343-349.
6. Soares D.M., Machado R.R., Yamashiro L.H., Melo M.C., Souza G.E. Cytokine-induced neutrophil chemoattractant (CINC)-1 induces fever by a prostaglandin-dependent mechanism in rats. Brain Res 2008, 1233:79-88.
7. Roth J., De Souza G.E. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res 2001, 34:301-314.
8. Blatteis C.M. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther 2006, 111:194-223.
9. +2 currents in identified cholinergic septal neurons expressing CXCR1 and CSCR2 receptor mRNAs. J Neurochem 2001, 78:960-971.
10. Campbell S.J., Wilcockson D.C., Butchart A.G., Perry V.H., Anthony D.C. Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J Neurochem 2002, 83:432-441.
11. Souza G.E.P., Cardoso R.A., Melo M.C.C., Fabrício A.S.C., Silva V.M.S., Lora M., De Brum-Fernandes A.J., Rae G.A., Ferreira S.H., Zampronio A.R. A comparative study of the antipyretic effects of indomethacin and dipyrone in rats. Inflamm Res 2002, 51:24-32.
12. Fabricio A.S., Rae G.A., Zampronio A.R., D'Orleans-Juste P., Souza G.E.P. Central endothelin ET(B) receptors mediate IL-1-dependent fever induced by preformed pyrogenic factor and corticotropin-releasing factor in the rat. Am J Physiol Regul Integr Comp Physiol 2006, 290:R164-R171.
13. Breder C.D., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988, 240:321-324.
14. Fabricio A.S., Tringali G., Pozzoli G., Melo M.C., Vercesi J.A., Souza G.E., Navarra P. Interleukin-1 mediates endothelin-1-induced fever and prostaglandin production in the preoptic area of rats. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1515-R1523.
15. Blessing W.W., Nalivaiko E. Raphe magnus/pallidus neurons regulate tail but not mesenteric arterial blood flow in rats. Neuroscience 2001, 105:923-929.
16. Nakamura Y., Nakamura K., Matsumura K., Kobayashi S., Kaneko T., Morrison S.F. Direct pyrogenic input from prostaglandin EP3 receptor-expressing preoptic neurons to the dorsomedial hypothalamus. Eur J Neurosci 2005, 22:3137-3146.
17. Stitt J.T. Fever versus hyperthermia. Fed Proc 1979, 38:39-43.
18. Roth J., Rummel C., Barth S.W., Gerstberger R., Hübschle T. Molecular aspects of fever and hyperthermia. Immunol Allergy Clin North Am 2009, 29:229-245.
19. Coelho M.M., Luheshi G., Hopkins S.J., Pelá I.R., Rothwell N.J. Multiple mechanisms mediate antipyretic action of glucocorticoids. Am J Physiol 1995, 269:R527-R535.
20. Strijbos P.J., Hardwick A.J., Relton J.K., Carey F., Rothwell N.J. Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF. Am J Physiol 1992, 263:E632-E636.
21. Fabricio A.S., Veiga F.H., Cristofoletti R., Navarra P., Souza G.E. The effects of selective and nonselective cyclooxygenase inhibitors on endothelin-1-induced fever in rats. Am J Physiol Regul Integr Comp Physiol 2005, 288:R671-R677.
22. Kanashiro A., Pessini A.C., Machado R.R., Malvar D.do.C., Aguiar F.A., Soares D.M., do Vale M.L., de Souza G.E. Characterization and pharmacological evaluation of febrile response on zymosan-induced arthritis in rats. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1631-R1640.
23. Fabricio A.S.C., Silva C.A.A., Rae G.A., D'Orléans-Juste P., Souza G.E.P. Essential role for endothelin ETB receptors in fever induced by LPS (E. coli) in rats. Br J Pharmacol 1998, 125:542-548.
24. Pessini A.C., Santos D.R., Arantes E.C., Souza G.E.P. Mediators involved in the febrile response induced by Tityus serrulatus scorpion venom in rats. Toxicon 2006, 48:556-566.
25. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 1986, 6:2908-2914.
26. Rivier C.L., Plotsky P.M. Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 1986, 48:475-494.
27. Fisher L., Rivier C., Rivier J., Brown M. Differential antagonist activity of α-helical CRF 9-41 in three bioassay systems. Endocrinology 1991, 129:1312-1316.
28. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
29. Rivier J., Spiess J., Vale W. Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A 1983, 80:4851-4855.
30. Wong M.L., Licinio J., Pasternak K.I., Gold P.W. Localization of Corticotropin-Releasing Hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 1994, 135:2275-2278.
31. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 2002, 23:71-77.
32. Irwin M., Vale W., Rivier C. Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. Endocrinology 1990, 126:2837-2844.
33. Rivest S., Rivier C. The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr Rev 1995, 16:177-199.
34. Heinrichs S.C., Richard D. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 1999, 33:35-39.
35. Lundkvist J., Chai Z., Teheranian R., Hasanvan H., Bartfai T., Jenck F., Widmer U., Moreau J.L. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 1996, 309:195-200.
36. Brown M.R., Fisher L.A., Rivier J., Spiess J., Rivier C., Vale W. Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci 1982, 30:207-210.
37. LeFeuvre R.A., Rothwell N., Stock M.J. Activation of brown fat thermogenesis in response to central injection of corticotropin releasing hormone in the rat. Neuropharmacology 1987, 26:1217-1221.
38. Diamant M., De Wied D. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. Endocrinology 1991, 129:446-454.
39. Zampronio A.R., Melo M.C.C., Silva C.A.A., Poll S., Hopkins S.J., Souza G.E.P. Involvement of CRH in fever induced by a distinct pre-formed pyrogenic factor (PFPF). Inflam Res 2000, 49:1-7.
40. Luheshi G., Rothwell N. Cytokines and fever. Int Arch Allergy Immunol 1996, 109:301-307.
41. Eckart K., Radulovic J., Radulovic M., Jahn O., Blank T., Stiedl O., Spiess J. Actions of CRF and its analogs. Curr Med Chem 1999, 6:1035-1053.
42. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 receptors. Proc Natl Acad Sci U S A 2001, 98:2843-2848.
43. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 2001, 98:7570-7575.
44. De Fanti B.A., Martinez J.A. Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res 2002, 930:37-41.
45. Telegdy G., Adamik A., Tóth G. The action of urocortins on body temperature in rats. Peptides 2006, 27:2289-2294.
46. Telegdy G., Adamik A. Involvement of CRH receptors in urocortin-induced hyperthermia. Peptides 2008, 29:1937-1942.
47. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
48. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis R.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology 1996, 137:2167-2170.
49. Lacroix S., Rivest S.J. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain. J Chem Neuroanat 1996, 10:53-71.
50. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, New York.
51. Romanovsky A.A., Ivanov A.I., Shimansky Y.P. Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality. J Appl Physiol 2002, 92:2667-2679.
52. Gordon C.J. Thermal biology of the laboratory rat. Physiol Behav 1990, 47:963-991.
53. Lodge D.J., Lawrence A.J. The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:451-458.
54. Morin S.M., Ling N., Liu X.J., Kahl S.D., Gehlert D.R. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 1999, 92:281-291.
55. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., De Souza E.B. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 1996, 17:166-172.
56. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000, 428:191-212.
57. O'leary D.S., Johnson J.M., Taylor W.F. Mode of neural control mediating rat tail vasodilation during heating. J Appl Physiol 1985, 59:1533-1538.
58. Gordon C.J., Puckett E., Padnos B. Rat tail skin temperature monitored noninvasively by radiotelemetry: characterization by examination of vasomotor responses to thermomodulatory agents. J Pharmacol Toxicol Methods 2002, 47:107-114.
59. Arase K., York D.A., Shimizu H., Shargill N., Bray G.A. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol 1988, 255:E255-E259.
60. Smagin G.N., Heinrichs S.C., Dunn A.J. The role of CRH in behavioral responses to stress. Peptides 2001, 22:713-724.
61. Hauger R.L., Risbrough V., Brauns O., Dautzenberg F.M. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 2006, 5:453-479.
62. Epstein Y., Hadad E., Shapiro Y. Pathological factors underlying hyperthermia. J Therm Biol 2004, 29:487-494.
63. Spina M., Merlo-Pich E., Chan R.K.W., Basso A.M., Rivier J., Vale W., Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996, 273:1561-1564.
64. Smagin G.N., Howell L.A., Ryan D.H., De Souza E.B., Harris R.B.S. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport 1998, 9:1601-1606.
65. Skelton K.H., Owens M.J., Nemeroff C.B. The neurobiology of urocortin. Regul Pept 2000, 93:85-92.
66. Kozics T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 1998, 391:1-10.
67. Bittencourt J.C., Vaughan J., Arias C., Rissman R.A., Vale W.W., Sawchenko P.E. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 1999, 415:285-312.
68. Gysling K., Forray M.I., Haeger P., Daza C., Rojas R. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?. Brain Res Brain Res Rev 2004, 47:116-125.
69. Kozicz T. On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. Gen Comp Endocrinol 2007, 153:235-240.
70. Pan W., Kastin A.J. Urocortin and the brain. Prog Neurobiol 2008, 84:148-156.
71. Currie P.J., Coscina D.V., Bishop C., Coiro C.D., Koob G.F., Rivier J., Vale W. Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient. Brain Res 2001, 916:222-228.
72. Bray G.A. Nutrient balance and obesity: an approach to control of food intake in humans. Med Clin North Am 1989, 73:29-45.
73. Cullen M.J., Ling N., Foster A.C., Pelleymounter M.A. Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology 2001, 142:992-999.
74. Fisher L.A. Corticotropin-releasing factor and autonomic-cardiovascular responses to stress. Stress, neuropeptides and systemic disease 1991, 95. Academic Press, San Diego. J.A. McCubbin, P.G. Kaufmann, C.B. Nemeroff (Eds.).
75. Gulyas J., Rivier C., Perrin M., Koerber S.C., Sutton S., Corrigan A., Lahrichi S.L., Craig A.G., Vale W., Rivier J. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing-factor. Proc Natl Acad Sci U S A 1995, 92:10575-10579.
76. Sanghvi R., Mogalian E., Machatha S.G., Narazaki R., Karlage K.L., Jain P., Tabibi S.E., Glaze E., Myrdal P.B., Yalkowsky S.H. Preformulation and pharmacokinetic studies on antalarmin: a novel stress inhibitor. J Pharm Sci 2009, 98:205-214.
77. Djouma E., Card K., Lodge D.J., Lawrence A.J. The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of Fawn-Hooded rats. Eur J Neurosci 2006, 23:3319-3327.
78. Banerjee A., Shen P.J., Ma S., Bathgate R.A., Gundlach A.L. Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 2010, 58:145-155.
79. Rothwell N.J. Central action of thermogenesis by prostaglandins: dependence on CRF. Horm Metab Res 1990, 22:616-618.
80. Coelho M.M., Pela I.R., Rothwell N.J. Dexamethasone inhibits the pyrogenic activity of prostaglandin F2 alpha, but not prostaglandin E2. Eur J Pharmacol 1993, 238:391-394.
81. Engblom D., Ek M., Saha S., Ericsson-Dahlstrand A., Jakobsson P.J., Blomqvist A. Prostaglandins as inflammatory messengers across the blood-brain barrier. J Mol Med 2002, 80:5-15.
82. Cao C., Matsumura K., Yamagata K., Watanabe Y. Induction by lipopolysaccharide of COX-2 mRNA in the brain: its possible role in the febrile response. Brain Res 1995, 697:187-196.
83. Cao C., Matsumura K., Yamagata K., Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1α: a possible site of prostaglandin synthesis responsible for fever. Brain Res 1996, 733:263-272.
84. Lugarini F., Hrupka B.J., Schwartz G.J., Plata-Salaman C.R., Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am J Physiol Regul Integr Comp Physiol 2002, 283:R862-R868.
85. Breder C.D., Dewitt D., Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 1995, 355:296-315.
86. Brune K., Alpermann H. Non-acidic pyrazoles: inhibition of prostaglandin production, carrageenan oedema and yeast fever. Agents Actions 1983, 13:360-363.